Kerry J Savage Selected Research

Lymphoproliferative Disorders (Lymphoproliferative Disorder)

1/2020

Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma-type post-transplant lymphoproliferative disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kerry J Savage Research Topics

Disease

36	Hodgkin Disease (Hodgkin's Disease) 12/2023 - 02/2005
30	Neoplasms (Cancer) 03/2024 - 01/2005
30	Lymphoma (Lymphomas) 03/2024 - 02/2005
23	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2005
18	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 03/2024 - 01/2008
13	B-Cell Lymphoma (Lymphoma, B Cell) 03/2024 - 08/2005
10	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2023 - 02/2005
10	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2021 - 12/2006
9	Melanoma (Melanoma, Malignant) 01/2021 - 06/2008
7	Disease Progression 10/2019 - 05/2007
6	T-Cell Lymphoma (Lymphoma, T Cell) 11/2021 - 01/2008
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2022 - 11/2014
4	Neutropenia 10/2018 - 09/2016
3	Febrile Neutropenia 01/2022 - 02/2016
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 03/2024 - 01/2023
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 11/2020
2	Exanthema (Rash) 10/2019 - 01/2018
1	Hepatitis 03/2024
1	Pneumonia (Pneumonitis) 03/2024
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023
1	Primary Cutaneous Anaplastic Large Cell Lymphoma 01/2023
1	Mycosis Fungoides 01/2023
1	Plasmablastic Lymphoma 10/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Vitiligo 01/2022
1	Uveal melanoma 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2021
1	Sclerosis 10/2021
1	Fever (Fevers) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021

Drug/Important Bio-Agent (IBA)

23	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 09/2012
21	Rituximab (Mabthera)FDA Link 01/2022 - 09/2009
20	Brentuximab VedotinIBA 03/2024 - 06/2012
14	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 10/2012
14	Vincristine (Oncovin)FDA LinkGeneric 12/2023 - 10/2012
13	NivolumabIBA 03/2024 - 01/2015
13	Prednisone (Sone)FDA LinkGeneric 12/2023 - 10/2012
13	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 01/2010
9	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 09/2012
9	Vinblastine (Vinblastine Sulfate)FDA Link 01/2022 - 09/2012
6	Anaplastic Lymphoma KinaseIBA 12/2023 - 07/2009
6	LigandsIBA 10/2018 - 03/2011
5	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2016
5	Methotrexate (Mexate)FDA LinkGeneric 12/2023 - 06/2015
5	Bendamustine Hydrochloride FDA Link 01/2022 - 01/2018
5	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2011
4	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 02/2015
4	ParaffinIBA 01/2022 - 09/2015
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2005
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 09/2012
3	IpilimumabIBA 01/2022 - 01/2015
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2017
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2017
3	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 06/2015
3	Formaldehyde (Formol)FDA Link 11/2017 - 09/2015
2	Dihydrotachysterol (AT 10)IBA 03/2024 - 02/2010
2	thiamine triphosphorate (TTP)IBA 03/2024 - 06/2014
2	ibrutinibIBA 01/2023 - 01/2017
2	Complement System Proteins (Complement)IBA 11/2022 - 03/2005
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022 - 01/2018
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 06/2015
2	CTLA-4 AntigenIBA 12/2021 - 01/2017
2	AnthracyclinesIBA 01/2021 - 01/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2019 - 01/2017
2	Monoclonal AntibodiesIBA 10/2019 - 01/2017
2	Gemcitabine FDA Link 01/2019 - 01/2017
2	Guanosine Diphosphate (GDP)IBA 01/2019 - 01/2017
2	Lipase (Acid Lipase)FDA Link 10/2018 - 09/2016
2	R-CHOP protocolIBA 10/2016 - 10/2009
2	10-propargyl-10-deazaaminopterin FDA Link 02/2016 - 03/2011
2	enzastaurinIBA 01/2016 - 05/2007
2	TNF Receptor-Associated Factor 1IBA 01/2007 - 02/2005
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 03/2024
1	tislelizumabIBA 01/2023
1	Bexarotene (LGD1069)FDA Link 01/2023
1	Circulating Tumor DNAIBA 11/2022
1	MicroRNAs (MicroRNA)IBA 11/2021
1	SphingolipidsIBA 11/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	SuspensionsIBA 10/2021
1	NS 11IBA 10/2021
1	Small Cytoplasmic RNAIBA 10/2021
1	TTI-621IBA 01/2021
1	trametinibIBA 01/2021
1	dabrafenibIBA 01/2021
1	AntigensIBA 01/2020

Therapy/Procedure

38	Therapeutics 12/2023 - 01/2008
30	Drug Therapy (Chemotherapy) 03/2024 - 12/2005
9	Stem Cell Transplantation 12/2023 - 06/2012
8	Radiotherapy 12/2021 - 11/2008
3	Cell Transplantation 10/2023 - 06/2015
2	Immunotherapy 01/2022 - 01/2019
2	Transplantation 01/2022 - 06/2015
2	Combined Modality Therapy 10/2019 - 11/2008
2	Hematopoietic Stem Cell Transplantation 06/2015 - 01/2008
1	Precision Medicine 11/2022
1	Radioimmunotherapy 01/2022
1	Contraindications 01/2021
1	Organ Transplantation 01/2020